Literature DB >> 12027581

The dominance of the microenvironment in breast and ovarian cancer.

Calvin D Roskelley1, Mina J Bissell.   

Abstract

That cancer development is a multistep process, driven in large part by genetic change, is well established. However, it is becoming increasingly clear that, prior to its emergence, the tumorigenic phenotype must overcome the suppressive effects of the surrounding microenvironment. Because the microenvironment is tissue-specific, cancer in each organ must develop unique strategies to overcome these normal epigenetic suppressors. Surprisingly, the induction of glandularity during the earliest stages of ovarian carcinoma development produces a microenvironment that has much in common with the normal mammary gland. This phenotypic convergence may explain why similar genetic and epigenetic changes appear to play a role in breast and ovarian tumor progression. Copyright 2002 Published by Elsevier Science Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12027581      PMCID: PMC3771861          DOI: 10.1006/scbi.2001.0417

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  76 in total

1.  E-cadherin expression in human epithelial ovarian cancer and normal ovary.

Authors:  K Sundfeldt; Y Piontkewitz; K Ivarsson; O Nilsson; P Hellberg; M Brännström; P O Janson; S Enerback; L Hedin
Journal:  Int J Cancer       Date:  1997-06-20       Impact factor: 7.396

Review 2.  The biology of ovarian cancer.

Authors:  N Auersperg; M I Edelson; S C Mok; S W Johnson; T C Hamilton
Journal:  Semin Oncol       Date:  1998-06       Impact factor: 4.929

Review 3.  Wnt signaling: a common theme in animal development.

Authors:  K M Cadigan; R Nusse
Journal:  Genes Dev       Date:  1997-12-15       Impact factor: 11.361

4.  Role of morphogenetic factors in metastasis of mammary carcinoma cells.

Authors:  S Meiners; V Brinkmann; H Naundorf; W Birchmeier
Journal:  Oncogene       Date:  1998-01-08       Impact factor: 9.867

5.  Increased E-cadherin expression in ovarian surface epithelium: an early step in metaplasia and dysplasia?

Authors:  S L Maines-Bandiera; N Auersperg
Journal:  Int J Gynecol Pathol       Date:  1997-07       Impact factor: 2.762

6.  Expression of E-cadherin, alpha-catenin and beta-catenin in normal ovarian surface epithelium and epithelial ovarian cancers.

Authors:  B R Davies; S D Worsley; B A Ponder
Journal:  Histopathology       Date:  1998-01       Impact factor: 5.087

Review 7.  Inactivation of the E-cadherin-mediated cell adhesion system in human cancers.

Authors:  S Hirohashi
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

8.  E-cadherin regulates anchorage-independent growth and survival in oral squamous cell carcinoma cells.

Authors:  S S Kantak; R H Kramer
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

9.  Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells.

Authors:  A Lochter; S Galosy; J Muschler; N Freedman; Z Werb; M J Bissell
Journal:  J Cell Biol       Date:  1997-12-29       Impact factor: 10.539

10.  Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies.

Authors:  V M Weaver; O W Petersen; F Wang; C A Larabell; P Briand; C Damsky; M J Bissell
Journal:  J Cell Biol       Date:  1997-04-07       Impact factor: 10.539

View more
  45 in total

1.  Hormone-responsive 3D multicellular culture model of human breast tissue.

Authors:  Xiuli Wang; David L Kaplan
Journal:  Biomaterials       Date:  2012-02-04       Impact factor: 12.479

2.  The stiffness of collagen fibrils influences vascular smooth muscle cell phenotype.

Authors:  Dennis P McDaniel; Gordon A Shaw; John T Elliott; Kiran Bhadriraju; Curt Meuse; Koo-Hyun Chung; Anne L Plant
Journal:  Biophys J       Date:  2006-12-08       Impact factor: 4.033

3.  Antagonistic enzymes may generate alternate phase transitions leading to ephemeral gels.

Authors:  Sébastien Giraudier; Véronique Larreta-Garde
Journal:  Biophys J       Date:  2007-04-27       Impact factor: 4.033

4.  Core-shell hydrogel beads with extracellular matrix for tumor spheroid formation.

Authors:  L Yu; S M Grist; S S Nasseri; E Cheng; Y-C E Hwang; C Ni; K C Cheung
Journal:  Biomicrofluidics       Date:  2015-04-17       Impact factor: 2.800

Review 5.  Calcium channels and pumps in cancer: changes and consequences.

Authors:  Gregory R Monteith; Felicity M Davis; Sarah J Roberts-Thomson
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

6.  A galectin-3-dependent pathway upregulates interleukin-6 in the microenvironment of human neuroblastoma.

Authors:  Ayaka M Silverman; Rie Nakata; Hiroyuki Shimada; Richard Sposto; Yves A DeClerck
Journal:  Cancer Res       Date:  2012-03-02       Impact factor: 12.701

7.  Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse.

Authors:  Feng-Ju Huang; Weon-Kyoo You; Paolo Bonaldo; Thomas N Seyfried; Elena B Pasquale; William B Stallcup
Journal:  Dev Biol       Date:  2010-06-27       Impact factor: 3.582

8.  Expression of cell cycle regulator cdk2ap1 suppresses tumor cell phenotype by non-cell-autonomous mechanisms.

Authors:  Olga Zolochevska; Marxa L Figueiredo
Journal:  Oral Oncol       Date:  2009-06-09       Impact factor: 5.337

9.  Association of invasion-promoting tenascin-C additional domains with breast cancers in young women.

Authors:  David S Guttery; Rachael A Hancox; Kellie T Mulligan; Simon Hughes; Sinead M Lambe; J Howard Pringle; Rosemary A Walker; J Louise Jones; Jacqueline A Shaw
Journal:  Breast Cancer Res       Date:  2010-08-02       Impact factor: 6.466

10.  Matrix rigidity activates Wnt signaling through down-regulation of Dickkopf-1 protein.

Authors:  Maria V Barbolina; Yiuying Liu; Hilal Gurler; Mijung Kim; Andre A Kajdacsy-Balla; Lisa Rooper; Jaclyn Shepard; Michael Weiss; Lonnie D Shea; Peter Penzes; Matthew J Ravosa; M Sharon Stack
Journal:  J Biol Chem       Date:  2012-11-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.